Umbral's Partner PhyeinMed Engages New Advisor-UMB.c
by @thenewswire on April 13, 2017
(TheNewswire)
Vancouver, B.C. / TheNewswire / April 13, 2017 - UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral” or “Company”) and the the management of PhyeinMed Inc. (“PhyeinMed”) a Health Canada Stage 5 applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations) are pleased to introduce Ms. Zena Prokosh as Regulatory Compliance Advisor to PhyeinMed Inc.
Zena Prokosh, CEO and founder of Zreyas Consulting Inc, offers regulatory compliance advice, application assistance, liaison to Health Canada and other related consulting services, to businesses and individuals alike within the cannabis industry, including applicants of all stages, under the ACMPR. Zena holds a B.Sc. in Biology from UBC and acquired her knowledge of medicinal plants while employed as the Curator and Germplasm PlantSMART Research Technician / Lab Manager at the UBC Charles Fipke Centre for Innovative Research, in Kelowna. She applied this experience to cannabis during her tenure as an Alternate Responsible Person In Charge (ARPIC), with THC Biomed International Ltd. During her three years as an ARPIC, she developed a fluency in MMP / ACMP Regulations which, allowed her to play an integral role in navigating the company through the MMPR/ACMPR licensing process, resulting in successfully obtaining a Production License. In addition, Zena has further advanced her knowledge of cannabis through being accepted to and attending the 2016 Masterclass Medicinal Cannabis® held in Leiden, Netherlands, hosted by Dr. Arno Hazekamp."
As a side note:
Dr. Arno Hazekamp, who's 2013 publication; Hazekamp, A., and Heerdink, E.R. (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. Eur. J. Clin. Pharmacy. Published online April 16, 2013., was included in an addendum (May 2013) to Health Canada's Information for Health Care Professionals - Cannabis (marihuana, marijuana) and the cannabinoids, to suggest the daily dose of dried cannabis for medical purposes, to be used by patients.
Zena will assist PhyeinMed as required with regulatory compliance relating to the application and information requests, quality and security controls during construction and her valuable advice and assistance during Health Canada inspections.
About Umbral Energy Corp.
The Company is currently listed as a junior resource issuer having mineral exploration projects. The Company is considering other activities to increase shareholder value, including non-resource projects.
The Company has mineral exploration projects in Utah, Nevada and Quebec. In addition the Company has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.
ON BEHALF OF THE BOARD OF DIRECTORS OF UMBRAL ENERGY CORP.
“Jag Bal”
Jagdip Bal President and CEO
NEITHER CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Copyright (c) 2017 TheNewswire - All rights reserved.
